Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age | 0.328 | |||
< 70 | Reference | |||
≤ 70 | 1.553 (0.643–3.753) | |||
Gender | 0.974 | |||
Male | Reference | |||
Female | 0.985 (0.397–2.443) | |||
Histological type | 0.986 | |||
Differentiated | Reference | |||
Undifferentiated | 1.008 (0.424–2.393) | |||
pT | 0.022* | 0.019* | ||
T2,3 | Reference | Reference | ||
T4 | 3.035 (1.176–7.829) | 3.162 (1.212–8.251) | ||
pN | 0.103 | |||
− | Reference | |||
+ | 5.315 (0.713–39.627) | |||
Lymphatic invasion | 0.399 | |||
− | Reference | |||
+ | – | |||
Venous invasion | 0.418 | |||
− | Reference | |||
+ | 2.295 (0.308–17.105) | |||
Operation | 0.292 | |||
DG + PG | Reference | |||
TG | 1.628 (0.657–4.034) | |||
Adjuvant chemotherapy | 0.682 | |||
− | Reference | |||
+ | 1.219 (0.473–3.143) | |||
SIS | 0.013* | 0.021* | ||
0,1 | Reference | Reference | ||
2 | 3.069 (1.270–7.417) | 2.847 (1.172–6.919) | ||
mGPS | 0.478 | 0.690 | ||
0 | Reference | Reference | ||
1,2 | 1.557 (0.458–5.290) | 1.284 (0.376–4.387) | ||
CAR | 0.852 | 0.904 | ||
< 0.03 | Reference | Reference | ||
0.03 ≤ | 0.922 (0.391–2.171) | 1.056 (0.436–2.554) | ||
LNR | 0.050 | 0.066 | ||
< 0.067 | Reference | Reference | ||
0.067 ≤ | 2.481 (0.999–6.164) | 2.409 (0.945–6.142) |